Summary
CVS Health Corporation (CVS) filed an 8-K on March 10, 2022, to announce a significant change in its Board of Directors leadership. David W. Dorman, the current Chair of the Board, has indicated his intention to retire at the end of his current term and will not seek re-election at the upcoming Annual Meeting of Stockholders on May 11, 2022. This retirement is stated to be amicable and not due to any disagreements. In conjunction with Mr. Dorman's upcoming departure, the Board has appointed Roger N. Farah, an existing independent director, to become the new Chair of the Board, effective May 11, 2022, contingent upon his re-election. Additionally, independent director Tony L. White will also be retiring from the Board due to reaching the mandatory retirement age. These leadership transitions are formally announced via a press release filed as an exhibit to this 8-K.
Key Highlights
- 1Current Board Chair David W. Dorman will retire and not stand for re-election at the May 11, 2022 Annual Meeting.
- 2Mr. Dorman's retirement is not a result of any disagreements with the company.
- 3Independent Director Tony L. White will also retire from the Board due to reaching mandatory retirement age.
- 4Roger N. Farah, an existing independent director, has been selected to succeed Mr. Dorman as Chair of the Board.
- 5Mr. Farah's appointment as Chair is effective May 11, 2022, subject to his re-election.
- 6The company issued a press release on March 10, 2022, detailing these leadership changes.